This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| TOP Programme | |
|---|---|
| Name | TOP Programme |
| Type | International initiative |
| Formed | 2012 |
| Headquarters | Geneva |
| Region | Global |
| Leader | Director-General (2019–present) |
TOP Programme
The TOP Programme is an international initiative established to enhance transparency, openness, and reproducibility across scientific research and institutional practices. It coordinates policy development, standard-setting, and capacity-building involving national agencies, multilateral organizations, philanthropic foundations, and major research institutions. Stakeholders include research funders, journal publishers, professional societies, and universities collaborating to align incentives and infrastructure.
The Programme brings together actors such as the World Health Organization, United Nations Educational, Scientific and Cultural Organization, European Commission, National Institutes of Health, Wellcome Trust, Bill & Melinda Gates Foundation, Howard Hughes Medical Institute, Max Planck Society, and Royal Society to develop common principles. It interacts with publishers including Nature Publishing Group, Elsevier, Wiley-Blackwell, Springer Nature, PLOS, and BMJ Group to integrate policy into editorial workflows. The initiative also liaises with standards bodies and infrastructure providers like Crossref, ORCID, DataCite, FAIRsharing, and GitHub to promote persistent identifiers and metadata best practices.
Origins trace to reproducibility concerns highlighted in reports by the National Academies of Sciences, Engineering, and Medicine, analysis from the Reproducibility Project: Psychology, and investigations published in Science and Nature. Early pilots were influenced by policy recommendations from the European Research Council and workshops convened by the Wellcome Trust and NIH Office of Science Policy. The initiative evolved through multi-stakeholder summits hosted in cities such as Geneva, London, Washington, D.C., Berlin, and Paris, and adopted phased guidelines following consultations with the American Association for the Advancement of Science, Canadian Institutes of Health Research, Australian Research Council, Deutsche Forschungsgemeinschaft, and leading universities including Harvard University, University of Oxford, Stanford University, University of Cambridge, and University of Tokyo.
Primary objectives include improving methodological transparency championed by organizations like Cochrane, enhancing data availability endorsed by PLOS, and standardizing reporting practices promoted by CONSORT and PRISMA guideline groups. The scope spans biomedical fields covered by Centers for Disease Control and Prevention-affiliated research, social sciences influenced by projects at London School of Economics, and computational studies from institutions such as MIT and ETH Zurich. The programme supports adoption of open data mandates similar to policies from European Research Council grants, promotes preprint dissemination in venues like bioRxiv and arXiv, and encourages code sharing through platforms like GitLab and Bitbucket.
Implementation strategies include model policies, training curricula, and audited compliance pathways developed with partners including Committee on Publication Ethics and International Committee of Medical Journal Editors. Operational activities involve pilot rollouts at funding agencies such as UK Research and Innovation and National Science Foundation, integration with editorial systems used by Crossref members, and technical interoperability efforts with registries like ClinicalTrials.gov and ISRCTN. Capacity-building workshops have been delivered in collaboration with research libraries like Library of Congress analogs, national research infrastructures such as ELIXIR, and computing centers including CERN and Compute Canada.
A multi-stakeholder steering committee comprised representatives from bodies including the Organisation for Economic Co-operation and Development, World Bank, European Commission, Wellcome Trust, Gates Foundation, and major universities provides governance oversight. Funding streams combine contributions from philanthropic organizations (e.g., Wellcome Trust, Gates Foundation), membership fees from publisher consortia including International Association of Scientific, Technical and Medical Publishers, and grant awards from agencies like National Institutes of Health and Horizon 2020. Independent advisory panels include experts drawn from Royal Society fellows, members of the National Academy of Sciences, and leaders from professional societies such as the American Psychological Association.
Reported outcomes include wider adoption of data availability statements in journals affiliated with PLOS, increased preprint submissions to bioRxiv and medRxiv, and strengthened reproducibility checks in flagship titles from Nature Publishing Group and Science. Funders such as Wellcome Trust and European Research Council have aligned grant conditions with core principles, and repositories like Zenodo and Figshare report increased deposits. Evaluations have cited collaborations with the Reproducibility Project: Cancer Biology and contributions to meta-research published in PNAS and The Lancet.
Critics from constituencies including some research-intensive universities, publisher advocates, and disciplinary societies such as the American Chemical Society have raised concerns about administrative burden, feasibility for researchers in low-resource settings represented by institutions in Sub-Saharan Africa and Southeast Asia, and potential unintended consequences similar to debates around policies from NIH and European Commission. Debates have referenced disputes over data privacy and patient confidentiality involving HIPAA-related frameworks, tensions over intellectual property highlighted by World Intellectual Property Organization stakeholders, and controversies echoing past conflicts in open science dialogues involving Elsevier and Sci-Hub disputes.
Category:Open science initiatives